1、State of Digital HealthGlobal|Q1 2024Global data and analysis on dealmaking,funding,and exits by private market digital health companiesState of Digital Health2 2Make smartertech decisions.Our platform will help you discover,understand,and manage your response to emerging tech.Make confident tech de

2、cisions that drive growth,improve operations,and beat the competition with CB Insights.IIIITry our platform free!Sign up for a free trialTLDR$3.7BGlobal digital health funding.Digital health funding rebounded in Q124,growing 48%QoQ.However,quarterly funding was still down 12%vs.Q123 and 63%vs.Q122.M

3、eanwhile,digital health deal count fell to its lowest quarterly level since 2014 in Q124.See the data 3$16.4MAverage deal size in 2024 so far,up 38%from 2023.After dropping from$23.1M in 2021 to$11.9M in 2023,average deal size is up to$16.4M in 2024 so far.This is being driven in part by the resurge

4、nce of mega-round deals.In Q124,these deals accounted for their second-highest share of quarterly funding since 2022.See the data 44%QoQ growth in US digital health funding.US digital health funding grew 44%QoQ in Q124.However,the US also saw deals drop to 144 the fewest in a quarter since 2013.Desp

5、ite the decline,the US still saw the majority of global digital health deals and funding in Q124.The US also secured 6 out of 7 digital health mega-rounds in the quarter.See the data 7$100M+mega-rounds.Digital health mega-rounds rebounded QoQ in Q124.The largest digital health deal of the quarter we

6、nt to Freenome a biotech company focused on cancer detection.While biotech drove the top deals,Q124 mega-rounds were spread across the digital health industry,from biomedical NLP to robotics for microsurgery.See the data 0New unicorns.No new unicorns(private companies valued at$1B+)emerged in Q124.W